tility Of Cancer Ratio And Cancer Plus Ratio In Differentiating Malignant Pleural Effusion And Tubercular Pleural Effusion.
Not Applicable
- Conditions
- Health Condition 1: J90- Pleural effusion, not elsewhere classified
- Registration Number
- CTRI/2024/04/065096
- Lead Sponsor
- Kasturba Medical College Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients Hospitalized In Kasturba Medical Hospital Consecutively For Lymphocytic Predominant Exudative Pleural Effusion
Exclusion Criteria
Patients With Transudative Pleural Effusion
Patients With Neutrophilic Predominant Exudative Pleural Effusion
Clinical Conditions That Increase Serum LDH(Sepsis,Cva,Hemolytic anemia,Hemolyzed samples,Hepatitis)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Calculating Cancer Ratio And Cancer Plus RatioTimepoint: Baseline
- Secondary Outcome Measures
Name Time Method Efficacy Of Cancer And Cancer Plus Ratio In Differentiating Malignant And Tubercular Pleural Effusion.Timepoint: At Time Of Discharge